THE USE OF PSYCHOTROPIC MEDICATION FOR PEOPLE WITH SEVERE DISABILITIES AND CHALLENGING BEHAVIOR: CURRENT STATUS AND FUTURE DIRECTIONS
Saved in:
KENNEDY, C.H., MEYER, K.A., THE USE OF PSYCHOTROPIC MEDICATION FOR PEOPLE WITH SEVERE DISABILITIES AND CHALLENGING BEHAVIOR: CURRENT STATUS AND FUTURE DIRECTIONS. JOURNAL OF THE ASSOCIATION FOR PERSONS WITH SEVERE HANDICAPS, THE, Vol. 23, no. 2 (1998), p. 83-97.
Ref.
71225
Location:
SIIS R.896
Palabras clave:
Discapacidad intelectual, Discapacidad severa, Fármacos, Modificación de conducta, Tendencias, Trastornos de la conducta
Discapacidad intelectual, Discapacidad severa, Fármacos, Modificación de conducta, Tendencias, Trastornos de la conducta
Similar Items: THE USE OF PSYCHOTROPIC MEDICATION FOR PEOPLE WITH SEVERE DISABILITIES AND CHALLENGING BEHAVIOR: CURRENT STATUS AND FUTURE DIRECTIONS
- COMBINING REWARD AND ESCAPE DRO TO REDUCE THE PROBLEM BEHAVIOR OF STUDENTS WITH SEVERE DISABILITIES
- INCREASING BEHAVIORS OF SEVERELY RETARDED AND AUTISTIC PERSONS
- RESPONDING TO PUPILS WITH SEVERE LEARNING DISABILITIES, WHO PRESENT CHALLENGING BEHAVIOUR
- SBIRT for adolescent drug and alcohol use: Current status and future directions
- COVARIATION WITHIN FUNCTIONAL RESPONSE CLASSES: IMPLICATIONS FOR TREATMENT OF SEVERE PROBLEM BEHAVIOR
- USE OF APPLIED BEHAVIORAL TECHNIQUES AND AN ADAPTIVE DEVICE TO TEACH LIP CLOSURE TO SEVERELY HANDICAPPED CHILDREN